Peroxisome proliferator-activated receptors and inflammation
Top Cited Papers
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 110 (3) , 371-385
- https://doi.org/10.1016/j.pharmthera.2005.08.007
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Educación, Cultura y Deporte
This publication has 154 references indexed in Scilit:
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004
- PPARα activation abolishes LDL-stimulated IL-8 production via AP-1 deactivation in human aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 2004
- Dual Function of Troglitazone in ICAM-1 Gene Expression in Human Vascular EndotheliumBiochemical and Biophysical Research Communications, 2001
- Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARγ)Gene, 1998
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Genes & Development, 1994
- Identification of Two mPPAR Related Receptors and Evidence for the Existence of Five Subfamily MembersBiochemical and Biophysical Research Communications, 1993
- Dietary n − 3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987